The safety of oral use of l-glutamine in middle-aged and elderly individuals

Nutrition

Volumn 26, Issue 4, 2010, Pages 375-381

  Galera, Siulmara Cristina ^a   Fechine, FranciscoVagnaldo ^a   Teixeira, Maria Jânia ^a   Coelho, Zirlane Castelo Branco ^a   de Vasconcelos, Raquel Cavalcante ^a   Leitão de Vasconcelos, Paulo Roberto ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Elderly; Glutamine; Middle age; Safety

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; CALCIUM CASEINATE; CASEIN; CREATININE; GLUTAMINE; LACTATE DEHYDROGENASE; LACTIC ACID; NUTRACEUTICAL; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AGING; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG METABOLISM; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION; LONG TERM CARE; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UREA NITROGEN BLOOD LEVEL;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CASEINS; CREATININE; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GLOMERULAR FILTRATION RATE; GLUTAMINE; HUMANS; KIDNEY; LIVER; MALE; MIDDLE AGED;

EID: 77349108360     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.05.013     Document Type: Article

References (56)

1. Curi R., Lagranha C.J., Doi S.Q., Sellitti D.F., Procopio J., Pithon-Curi T.C., et al. Molecular mechanisms of glutamine action. J Cell Physiol 204 (2005) 392-401
2. Matilla B., Ortíz J., González P., García-Díez F., Jorquera F., Culebras J.M., et al. Effects of parenteral nutrition supplemented with glutamine or glutamine dipeptides on liver antioxidant and detoxication systems in rats. Nutrition 16 (2000) 125-128
3. Bonet A., and Grau T. La glutamina, un aminoácido casi indispensable en el enfermo crítico. Med Intensiva 31 (2007) 402-406
4. Sacks G.S. Glutamine supplementation in catabolic patients. Ann Pharmacother 33 (1999) 348-354
5. Tapiero H., Mathé G., Couvreur P., and Tew K.D. Glutamine and glutamate. Biomed Pharmacother 56 (2002) 446-457
6. Grimble R.F. Immunonutrition. Curr Opin Gastroenterol 21 (2005) 216-222
7. Valencia E., Marin A., and Hardy G. Glutathione-nutritional and pharmacological viewpoints: part II. Nutrition 17 (2001) 485-486
8. Castell L.M., and Newsholme E.A. The effects of oral glutamine supplementation on athletes after prolonged, exhaustive exercise. Nutrition 13 (1997) 738-742
9. Valencia E., Marin A., and Hardy G. Impact of oral L-glutamine on glutathione, glutamine, and glutamate blood levels in volunteers. Nutrition 26 (2002) 367-370
10. Cynober L. Glutamine as an activator of immune cells: how does it work?. Nutrition 134 (1997) 688-689
11. Gao Z.Y., Li G., Najafi H., Wolf B.A., and Matschinsky F.M. Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes 48 (1999) 1535-1542
12. Conejero R., Bonet A., Grau T., Esteban A., Mesejo A., Montejo J.C., et al. Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: a randomized, single-blind, prospective, multicenter study. Nutrition 18 (2002) 716-721
13. Déchelotte P., Hasselmann M., Cynober L., Allaouchiche B., Coëffier M., Hecketsweiler B., et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 34 (2006) 598-604
14. García-de-Lorenzo A., Zarazaga A., García-Luna P.P., Gonzalez-Huix F., López-Martinez J., Miján A., et al. Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition 19 (2003) 805-811
15. Fürst P., Pogan K., and Stehle P. Glutamine dipeptides in clinical nutrition. Nutrition 13 (1997) 731-737
16. Rogero M.M., Tirapegui J., Pedrosa R.G., Castro I.A., Pires I.S., and Chem B. Effect of alanyl-glutamine supplementation on plasma and tissue glutamine concentrations in rats submitted to exhaustive exercise. Nutrition 22 (2006) 564-571
17. Garlick P.J. Assessment of the safety of glutamine and other amino acids. J Nutr 131 (2001) 2556S-61
18. Ziegler T.R., Benfell K., Smith R.J., Young L.S., Brown E., Ferrari-Baliviera E., et al. Safety and metabolic effects of L-glutamine administration in humans. JPEN 14 (1990) 137S-46
19. Papaléo Netto M. O estudo da velhice: histórico, definição do campo e termos básicos. In: Freitas E.V., Py L., Cançado F.A.X., Doll J., and Gorzoni M.L. (Eds). Tratado de geriatria e gerontologia. 2nd ed (2006), Guanabara Koogan, Rio de Janeiro 2-12
20. Wieman H.M. Avoiding common pitfalls of geriatric prescribing. Geriatrics 41 (1986) 81-89
21. Olagnero G., Bendersky S., Genevois C., Granzella L., and Montonati M.L. Alimentos funcionales: fibra, prebióticos, probióticos y simbióticos. Diaeta 25 (2007) 20-33
22. Olagnero G., Genevois C., Irei V., Marcenado J., and Bendersky S. Alimentos funcionales: conceptos, definiciones y marco legal global. Diaeta 25 (2007) 31-39
23. Ligthart G.J., Corberand J.X., Fournier C., Galanaud P., Hijmans W., Kennes B., et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 28 (1984) 47-55
24. Henry J.B. Diagnósticos clínicos e tratamento por métodos laboratoriais. 2nd ed. (1999), São Paulo: Manole
25. Burtis C.A., and Ashwood E.R. Tietz textbook of clinical chemistry. 2nd ed. (1994), WB Saunders, Philadelphia
26. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6 (1969) 24-27
27. Gella F.J., Olivella T., Cruz Pastor M., Arenas J., Moreno R., Durban R., et al. A simple procedure for routine determination of aspartate aminotransferase and alanine aminotransferase with pyridoxal phosphate. Clin Chim Acta 153 (1995) 241-247
28. Tietz N.W. Clinical guide on clinical laboratory tests. 4th ed. (1991), AACC Press, Washington, DC
29. Heyland D.K., Dhaliwalm R., Day A., Drover J., Cote H., and Wischmeyer P. Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study. JPEN 31 (2007) 109-118
30. Tietz N.W., Rinker D., and Shaw L.M. IFCC methods for the measurement of catalytic concentration of enzymes. Part 5: IFCC methods for alkaline phosphatase. J Clin Chem Clin Biochem 21 (1983) 731-748
31. Van Anken H.C., and Schiphorst M.E. A kinetic determination of ammonia in plasma. Clin Chim Acta 56 (1974) 151-157
32. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
33. International Physical Activity Questionnaire. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-short and longs forms. Revised 2002. Available at: http://www.ipaq.ki.se/downloads.htm. Accessed May 29, 2009.
34. Baretta E., and Peres K.G. Nível de atividade física e fatores associados em adultos no Município de Joaçaba, Santa Catarina (2007), Cad Saude Publica, Brazil 23:1595-602
35. Novak F., Heyland D.K., Avenell A., Drover J.W., and Su X. Glutamine supplementation in serious Illness: A systematic review of the evidence. Crit Care Med 30 (2002) 2022-2029
36. © Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 65 (2006) 250-263
37. Garlick P.J. The nature of human hazards associated with excessive intake of amino acids. J Nutr 134 (2004) 1633S-9
38. Roth E., Ochler R., Manhart N., Exner R., Wessner B., Strasser E., et al. Regulative potential of glutamine-relation to glutathione metabolism. Nutrition 18 (2002) 217-221
39. Roth E. Immune cell modulation by amino acids. Clin Nutr 26 (2007) 535-544
40. Vestal R.E. Aging and determinants of hepatic drug clearance. Hepatology 9 (1989) 331-334
41. Wyne H.A., Cope L.H., Mutch E., Rawlins M.D., Woodhouse K.W., and James O.F. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 9 (1989) 297-301
42. Dudrick P.S., and Souba W.W. Amino acids in surgical nutrition. Principles and practice. Surg Clin North Amer 71 (1991) 459-475
43. Hornsby-Lewis L., Shike M., Brown P., Klang M., Pearlstone D., and Brennam M.F. L-glutamine supplementation in home total parenteral nutrition patients: stability, safety, and effects on intestinal absorption. JPEN 18 (1994) 268-273
44. Lochs H., and Hübl W. Metabolic basis for selecting glutamine-containing substrates for parenteral nutrition. JPEN 14 (1990) 114S-7
45. Butterworth R.F. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 17 (2002) 221-227
46. Felipo V., and Butterworth R.F. Neurobiology of ammonia. Prog Neurobiol 67 (2002) 259-279
47. Berg U.B. Differences in decline in GFR with age between males and females. References data on clearance of inulin and PAH in potential kidney donors. Nephrol Dial Transplant 21 (2006) 577-582
48. Davies D.F., and Shok N.W. Age changes in glomerular filtration rate, effective renal plasma flow and tubular excretory capacity in adult males. J Clin Invest 29 (1950) 449-507
49. Beck L.H. The aging kidney. Defending a delicate balance of fluid and electrolytes. Geriatrics 55 (2000) 26-32
50. Silva F.G. The aging kidney: a review-part I. Int Urol Nephrol 37 (2005) 185-205
51. Lemos V.M. Considerações sobre medicamentos e o rim no idoso. In: Carvalho F.J.W. (Ed). Nefrologia em geriatria (2008), Rubio, Rio de Janeiro 40-53
52. Coffman T.M. Renal failure caused by therapeutic agents. In: Greenberg A. (Ed). Primer on kidney diseases (2001), Academic Press, San Diego 251-257
53. Raveh D., Kopyt M., Hite Y., Rudensky B., Sonnenblick M., and Yinnon A.M. Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. QJM 95 (2002) 291-297
54. Werneck de Carvalho F.J. Nefroproteção e envelhecimento. In: Carvalho F.J.W. (Ed). Nefrologia em geriatria (2008), Rubio, Rio de Janeiro 29-39
55. Cirillo M., Anastasio P., and De Santo N.G. Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant 20 (2005) 1791-1798
56. Consonello A., Pedone C., Corica F., Mussi C., Carboni P., Incalzi R.A., et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 165 (2005) 790-795